» Articles » PMID: 32197968

"Natural" is Not Synonymous with "Safe": Toxicity of Natural Products Alone and in Combination with Pharmaceutical Agents

Overview
Publisher Elsevier
Specialties Pharmacology
Toxicology
Date 2020 Mar 22
PMID 32197968
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

During the 25 years since the US Congress passed the Dietary Supplement Health and Education Act (DSHEA), the law that transformed the US Food and Drug Administration's (FDA's) authority to regulate dietary supplements, the dietary supplement market has grown exponentially. Retail sales of herbal products, a subcategory of dietary supplements, have increased 83% from 2008 to 2018 ($4.8 to $8.8 billion USD). Although consumers often equate "natural" with "safe", it is well recognized by scientists that constituents in these natural products (NPs) can result in toxicity. Additionally, when NPs are co-consumed with pharmaceutical agents, the precipitant NP can alter drug disposition and drug delivery, thereby enhancing or reducing the therapeutic effect of the object drug(s). With the widespread use of NPs, these effects can be underappreciated. We present a summary of a symposium presented at the Annual Meeting of the Society of Toxicology 2019 (12 March 2019) that discussed potential toxicities of NPs alone and in combination with drugs.

Citing Articles

Alkaloid-Based Isoxazolylureas: Synthesis and Effect in Combination with Anticancer Drugs on C6 Rat Glioma Model Cells.

Mukusheva G, Jalmakhanbetova R, Shaibek A, Nurmaganbetova M, Zhasymbekova A, Nurkenov O Molecules. 2024; 29(14).

PMID: 39064825 PMC: 11278957. DOI: 10.3390/molecules29143246.


Plant antibacterials: The challenges and opportunities.

Berida T, Adekunle Y, Dada-Adegbola H, Kdimy A, Roy S, Sarker S Heliyon. 2024; 10(10):e31145.

PMID: 38803958 PMC: 11128932. DOI: 10.1016/j.heliyon.2024.e31145.


The mechanisms of natural products for eye disorders by targeting mitochondrial dysfunction.

Sun G, Qu X, Jiang L, Chen Z, Wang T, Han X Front Pharmacol. 2024; 15:1270073.

PMID: 38725662 PMC: 11079200. DOI: 10.3389/fphar.2024.1270073.


Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives.

Gouda N, Alshammari S, Abourehab M, Alshammari Q, Elkamhawy A Inflammopharmacology. 2023; 31(6):2857-2883.

PMID: 37950803 DOI: 10.1007/s10787-023-01366-y.


Natural products for the treatment of depression: Insights into signal pathways influencing the hypothalamic-pituitary-adrenal axis.

Liu J, Meng T, Wang C, Cheng W, Zhang Q, Cheng G Medicine (Baltimore). 2023; 102(44):e35862.

PMID: 37932977 PMC: 10627670. DOI: 10.1097/MD.0000000000035862.


References
1.
Backman J, Olkkola K, Neuvonen P . Rifampin drastically reduces plasma concentrations and effects of oral midazolam. Clin Pharmacol Ther. 1996; 59(1):7-13. DOI: 10.1016/S0009-9236(96)90018-1. View

2.
Mathern G, Beninsig L, Nehlig A . Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: result of Epilepsia's survey. Epilepsia. 2014; 56(1):1-6. DOI: 10.1111/epi.12843. View

3.
Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson N, Leonova J . The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007; 152(7):1092-101. PMC: 2095107. DOI: 10.1038/sj.bjp.0707460. View

4.
Abe O, Ono T, Sato H, Muller F, Ogata H, Miura I . Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers. Eur J Clin Pharmacol. 2018; 74(6):775-783. DOI: 10.1007/s00228-018-2436-2. View

5.
Devinsky O, Patel A, Cross J, Villanueva V, Wirrell E, Privitera M . Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome. N Engl J Med. 2018; 378(20):1888-1897. DOI: 10.1056/NEJMoa1714631. View